Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Patients Blame Cost for Coverage Delay in England of Gilead Drug
WSJ Pharmalot
Fri, 01/23/15 - 08:21 am
UK
Gilead Sciences
patients
Sovaldi
hepatitis C
Gilead’s John Martin Named Morningstar CEO of 2014
Barron's
Wed, 01/21/15 - 06:00 pm
John Martin
Gilead Sciences
Pharma CEOs
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
Can Gilead Sciences Beat Hep-C Estimates?
Barron's
Tue, 01/20/15 - 03:59 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
TheStreet.com
Tue, 01/20/15 - 11:33 am
JPMHC 2015
drug pricing
CAR-T
biotech
Gilead Sciences
immuno-oncology
Duchenne Muscular Dystrophy
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Gilead's appeal for drug patent in India could see protracted case
The Hindu
Sat, 01/17/15 - 11:05 am
Gilead Sciences
India
hepatitis C
Sovaldi
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Aetna
Gilead Sciences
hepatitis C
AbbVie
Sovaldi
Harvoni
Viekira Pak
Gilead to appeal India patent ruling on hepatitis C drug
Yahoo/Reuters
Fri, 01/16/15 - 08:11 am
Gilead Sciences
India
patents
Sovaldi
hepatitis C
Insight - Big Pharma faces up to new price pressure from aggressive insurers
Yahoo/Reuters
Thu, 01/15/15 - 09:02 am
insurance
Big Pharma
drug pricing
Express Scripts
AbbVie
Gilead Sciences
AstraZeneca
Eli Lilly
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
WSJ Pharmalot
Thu, 01/15/15 - 08:59 am
India
patents
Gilead Sciences
Sovaldi
hepatitis C
Aetna CEO says no decision yet on how to cover hepatitis C drugs
Yahoo/Reuters
Wed, 01/14/15 - 09:01 am
Aetna
hepatitis C
AbbVie
Gilead Sciences
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1
TheStreet.com
Fri, 01/9/15 - 09:17 am
Celgene
Gilead Sciences
Express Scripts
Biogen Idec
Amicus Therapeutics
NPS Pharmaceuticals
Sanofi
Acadia
Orexigen
Pharmacyclics
Vertex Pharmaceuticals
Is Gilead Sciences Inc. Now a Takeover Target?
Motley Fool
Fri, 01/9/15 - 08:29 am
Gilead Sciences
M&A
Novartis
Pfizer
JNJ
Merck
Biotech’s Price Wars Are Just Beginning
Bloomberg
Fri, 01/9/15 - 08:01 am
biotech
AbbVie
Gilead Sciences
drug pricing
hepatitis C
Anthem selects Gilead as primary supplier of hepatitis C drugs
Yahoo/Reuters
Thu, 01/8/15 - 10:21 pm
Gilead Sciences
Anthem
hepatitis C
Gilead Sciences to liver disease treatment from Phenex for as much as $470 million
Yahoo/AP
Tue, 01/6/15 - 03:36 pm
Gilead Sciences
Phenex
NASH
liver disease
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
TheStreet.com
Tue, 01/6/15 - 08:52 am
Sanofi
MannKind
Gilead Sciences
Santhera
Puma Biotechnology
Bluebird Bio
Celgene
Pfizer
Biogen Idec
CVS Picks Gilead Hep C Drugs As Price War Looms
Investors.com
Mon, 01/5/15 - 04:04 pm
CVS
Gilead Sciences
Express Scripts
AbbVie
drug pricing
hepatitis C
Harvoni
Sovaldi
Why Gilead Sciences, Inc. Stock Plunged as Much as 14% in December
Motley Fool
Mon, 01/5/15 - 10:38 am
Gilead Sciences
AbbVie
Harvoni
Sovaldi
Express Scripts
hepatitis C
Pages
« first
‹ previous
…
65
66
67
68
69
70
71
72
73
…
next ›
last »